A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur
American Journal of Case Reports · 2024
DOI: 10.12659/ajcr.942810 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2024. Verfasst von Dong Ren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California Irvine Medical Center, Orange, CA, USA. Hauptthemen laut MEDLINE: Neoplasms, Connective Tissue, Soft Tissue Neoplasms, Mesenchymoma, Paraneoplastic Syndromes. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Phosphaturic mesenchymal tumor (PMT) is an extremely rare mesenchymal neoplasm that is commonly seen in bone and soft tissue. It is associated with a paraneoplastic syndrome, oncogenic osteomalacia, due to tumor-induced urinary phosphate wasting. It is demonstrated to be predominantly mediated by fibroblast growth factor 23 (FGF23)/fibroblast growth factor receptor 1 (FGFR1) axis. Clinically, PMT usually presents as a solitary lesion in the bone. The diagnosis of PMT is challenging due to its non-specific clinical manifestation, radiologic findings, and morphological features. CASE REPORT We report the case of a 50-year-old man presenting with multiple lytic bone lesions and associated pathologic fracture of the right femur, clinically suspicious for multiple myeloma or other metastatic malignant process. Resection from the right femur showed a hypercellular lesion composed of oval-to-spindled cells infiltrating the native trabecular bone with admixed multinucleated giant cells. Immunohistochemical (IHC) staining and in situ hybridization (ISH) demonstrated the tumor cells were positive for SATB2, ERG, FGFR1, and FGF23 ISH. DNA and RNA next-generation sequencing showed marked increases in mRNA levels of FGF23 and FGFR1. The constellation of clinicoradiologic, histomorphologic, IHC, and molecular findings supported a diagnosis of primary benign PMT. CONCLUSIONS This case report discusses a patient with PMT presenting with multifocal lesions due to tumor-induced osteomalacia at initial presentation. We hope that this report will increase the awareness of clinician and pathologists of PMT as a differential diagnosis in patients presenting with multifocal lytic bone lesions. In turn, this will prevent misdiagnosis and overtreatment of a typically benign process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, University of California Irvine Medical Center, Orange, CA, USA.
- Department of Laboratory Medicine, University of California Irvine Medical Center, Orange, CA, USA.
- Department of Radiology, University of California Irvine Medical Center, Orange, CA, USA.
Zitieren
APA
Ren, D., Wei, K., & Ifegwu, I. (2024). A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur. American Journal of Case Reports. https://doi.org/10.12659/ajcr.942810
Vancouver
Ren D, Wei K, Ifegwu I. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur. American Journal of Case Reports. 2024. doi:10.12659/ajcr.942810
BibTeX
@article{Ren2024,
author = {Ren, Dong and Wei, Katherine and Ifegwu, Ibe},
title = {A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur},
journal = {American Journal of Case Reports},
year = {2024},
doi = {10.12659/ajcr.942810}
}
EUVIMED